Skip to main content

The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding

Abstract

Introduction

The objective of this study was to prospectively compare the effectiveness of Ankaferd Blood Stopper (ABS) with dry sponges in cessation of bleeding in adult trauma cases with external bleeding due to extremity lacerations.

Methods

The study was conducted on patients with bleeding associated with extremity lacerations. All consecutive patients presented to the emergency department of a high-volume training hospital in Istanbul were recruited within the study period. Forty patients (group I) were compressed with ABS-soaked wet sponges, and 40 control patients (group II) were treated with compression using dry sterile sponges. The compresses were briefly removed at 1-min intervals and bleeding status was checked. Wounds were monitored for 0.5 h for bleeding recurrence. The patients were followed up for infection, and date of suture removal was noted.

Results

There were 26 male (65%) patients in the ABS group and the mean age was 42.9 ± 12.8 (range 20–72) years. In the control group, there were 24 male (60%) patients with a mean age of 45.4 ± 15.1 years (range 18–70). The bleeding duration was 2.1 ± 1.4 min in the ABS group and 2.7 ± 1.6 min in the control group. In the ABS group, bleeding duration was statistically significantly shorter than that of the control group (p = 0.001). No significant difference was noted in infection development and time taken to remove sutures. Primary suturing had to be performed in one patient in the ABS group and two patients in the control group. Among the remaining patients, bleeding recurred in six patients (15%) in the ABS group and 19 (47.5%) in the control group (p = 0.001).

Conclusion

Ankaferd Blood Stopper appears to be useful in controlling bleeding due to lacerations on the extremities in adults. Bleeding was stopped statistically significantly faster and bleeding recurred significantly less frequently in the ABS-treated group.

Trial Registration

ClinicalTrials.gov identifier: NCT03871452.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Beyazit Y, Kurt M, Kekili M, Göker H, Haznedaroğlu İC. Evaluation of hemostatic effects of Ankaferd as an alternative medicine. Altern Med Rev. 2010;15(4):329–36.

    PubMed  Google Scholar 

  2. 2.

    Goker H, Haznedaroglu IC, Ercetin S, et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res. 2008;36:163–7.

    Article  CAS  PubMed  Google Scholar 

  3. 3.

    Albayrak CU, Çalışkan Ü. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res. 2008;36:1447–9.

    Article  Google Scholar 

  4. 4.

    Akar N, Demiralp DO, Haznedaroğlu IC, et al. Functional proteomics of Ankaferd Blood Stopper. Turk J Hematol. 2010;27:70–7.

    Article  Google Scholar 

  5. 5.

    Haznedaroglu IC, Goker H. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper response. J Int Med Res. 2008;36:1448–9.

    Google Scholar 

  6. 6.

    Tuncer I, Doganay L, Ozturk O. Instant control of fundal variceal bleeding with a folkloric medicinal plant extract: Ankaferd Blood Stopper. Gastrointest Endosc. 2010;71:873–5.

    Article  PubMed  Google Scholar 

  7. 7.

    Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd Blood Stopper. Indian J Gastroenterol. 2010;29:166–8. https://doi.org/10.1007/s12664-010-0043-y.

    Article  PubMed  Google Scholar 

  8. 8.

    Karaman A, Torun E, Gürsoy S, Yurci A, Ozbakir O. Effectiveness of Ankaferd Blood Stopper in postpolypectomy bleeding. J Altern Complement Med. 2010;16:1027–8.

    Article  PubMed  Google Scholar 

  9. 9.

    Kurt M, Onal I, Akdogan M, et al. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures. Can J Gastroenterol. 2010;24:380–4.

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. The effect of a new hemostatic agent for difficult cases of non-variceal gastrointestinal bleeding: Ankaferd Blood Stopper. Hepatogastroenterol J. 2010;57:191–4.

    Google Scholar 

  11. 11.

    Purnak T, Ozaslan E, Beyazit Y, Haznedaroglu IC. Upper gastrointestinal bleeding in a patient with defective hemostasis successfully treated with Ankaferd Blood Stopper. Phytother Res. 2011;25:312–3.

    PubMed  Google Scholar 

  12. 12.

    Yarali N, Oruc M, Bay A, et al. A new hemostatic agent-Ankaferd Blood Stopper: management of gastrointestinal bleeding in an infant and other experiences in children. Pediatr Hematol Oncol. 2010;27:592–6.

    Article  PubMed  Google Scholar 

  13. 13.

    Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd Blood Stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy. 2008;40(Suppl 2):E262.

    Article  PubMed  Google Scholar 

  14. 14.

    Kurt M, Akdoğan M, İbiş M, Haznedaroğlu İC. Ankaferd Blood Stopper for gastrointestinal bleeding. J Invest Surg. 2009;22(3):201–6.

    Article  Google Scholar 

  15. 15.

    Ozaslan E, Purnak T, Yildiz A, Akar T, Avcioglu U, Haznedaroglu IC. The effect of Ankaferd Blood Stopper on severe radiation colitis. Endoscopy. 2009;41(Suppl 2):E321–2.

    Article  PubMed  Google Scholar 

  16. 16.

    Shorbagi A, Sivri B. Successful management of a difficult case of radiation proctopathy with Ankaferd Blood Stopper a novel indication. Gastrointest Endosc. 2010;72:666–7.

    Article  PubMed  Google Scholar 

  17. 17.

    Ozaslan E, Purnak T, Ozyigit G, Akyol F, Yildiz A, Haznedaroglu IC. No prolonged effect of Ankaferd Blood Stopper on chronic radiation proctitis. Endoscopy. 2010;42(Suppl 2):E271–2.

    Article  PubMed  Google Scholar 

  18. 18.

    Kurt M, Akdogan M, Onal IK, et al. Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis. 2010;42:196–9.

    Article  PubMed  Google Scholar 

  19. 19.

    Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. A new practical alternative for tumoural gastrointestinal bleeding: Ankaferd Blood Stopper. Dig Liver Dis. 2010;42:594–5.

    Article  PubMed  Google Scholar 

  20. 20.

    Zulfikar OB, Emiroglu HH, Kebudi R. Nasogastric application of topical Ankaferd Blood Stopper for bleeding from primary esophageal adenocarcinoma in a child with disseminated intravascular coagulation. Dig Liver Dis. 2011;43:247–8.

    Article  PubMed  Google Scholar 

  21. 21.

    Arslan S, Haznedaroğlu IC, Öz B, Göker H. Endobronchial application of Ankaferd Blood Stopper to control profuse lung bleeding leading to hypoxemia and hemodynamic instability. Resp Med CME. 2009;2:144–6.

    Article  Google Scholar 

  22. 22.

    Erçetin S, et al. Safety and effectiveness of Ankaferd Blood Stopper in dental surgery. Int J Hemat Oncol. 2010;20(1):1–5.

    Article  Google Scholar 

  23. 23.

    Baykul T, Alanoğlu G, Koçer G. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience. J Contemp Dent Pract. 2010;11(1):88–94.

    Article  Google Scholar 

  24. 24.

    Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective randomized controlled clinical trial of ABS in patients with acute anterior epistaxis. Eur Arch Otorhinolarlyngol. 2010;267(9):1377–81.

    Article  Google Scholar 

  25. 25.

    Lynen I, Sogut O, Kose R. The effectiveness of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model. Otolaryngol Head Neck Surg. 2011;145(5):840–4.

    Article  Google Scholar 

  26. 26.

    Al B, Yildirim C, Cavdar M, Zengin S, Büyükaslan H, Kalender ME. Effectiveness of Ankaferd Blood Stopper in the topical control of active bleeding due to cutaneous-subcutaneous incisions. Saudi Med J. 2009;30:1520–5.

    PubMed  Google Scholar 

Download references

Acknowledgements

I thank the participants of the study for their help in the accomplishment of the research and rendering accessibility of this information to the medical community.

Funding

No funding or sponsorship was received for this study or publication of this article. The article processing charges were funded by the author.

Authorship

The named author meets the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, takes responsibility for the integrity of the work as a whole, and has given approval for this version to be published.

Disclosures

Nazmiye Koyuncu has nothing to disclose.

Compliance with Ethics Guidelines

All procedures performed in studies involving human participants were in accordance with Haydarpasa Numune Training & Research Hospital Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.

Data Availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Nazmiye Koyuncu.

Additional information

Enhanced Digital Features

To view enhanced digital features for this article go to https://doi.org/10.6084/m9.figshare.7837928.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Koyuncu, N. The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding. Adv Ther 36, 1143–1149 (2019). https://doi.org/10.1007/s12325-019-00935-4

Download citation

Keywords

  • Ankaferd Blood Stopper
  • Bleeding
  • Direct compression
  • Emergency department
  • Emergency medicine
  • Hemorrhage
  • Laceration